Scorpius Holdings Inc (SCPX)
0.0303
+0.01
(+37.10%)
USD |
OTCM |
Jun 28, 15:57
Scorpius Holdings Research and Development Expense (TTM): 18.30M for March 31, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 18.30M |
| December 31, 2023 | 20.70M |
| September 30, 2023 | 24.07M |
| June 30, 2023 | 24.29M |
| March 31, 2023 | 23.29M |
| December 31, 2022 | 20.93M |
| September 30, 2022 | 18.49M |
| June 30, 2022 | 17.49M |
| March 31, 2022 | 16.98M |
| December 31, 2021 | 16.46M |
| September 30, 2021 | 16.20M |
| June 30, 2021 | 14.99M |
| March 31, 2021 | 13.56M |
| December 31, 2020 | 12.94M |
| September 30, 2020 | 12.03M |
| June 30, 2020 | 11.99M |
| March 31, 2020 | 12.62M |
| December 31, 2019 | 13.01M |
| September 30, 2019 | 15.20M |
| June 30, 2019 | 16.48M |
| March 31, 2019 | 16.53M |
| December 31, 2018 | 16.23M |
| September 30, 2018 | 13.24M |
| Date | Value |
|---|---|
| June 30, 2018 | 10.66M |
| March 31, 2018 | 9.328M |
| December 31, 2017 | 8.268M |
| September 30, 2017 | 7.992M |
| June 30, 2017 | 7.861M |
| March 31, 2017 | 7.486M |
| December 31, 2016 | 9.331M |
| September 30, 2016 | 22.03M |
| June 30, 2016 | 21.01M |
| March 31, 2016 | 19.82M |
| December 31, 2015 | 16.67M |
| September 30, 2015 | 2.204M |
| June 30, 2015 | 2.552M |
| March 31, 2015 | 2.814M |
| December 31, 2014 | 2.844M |
| September 30, 2014 | 3.024M |
| June 30, 2014 | 2.991M |
| March 31, 2014 | 2.831M |
| December 31, 2013 | 2.738M |
| September 30, 2013 | 2.433M |
| June 30, 2013 | 1.683M |
| March 31, 2013 | 1.172M |
| December 31, 2012 | 0.9029M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
11.99M
Minimum
Jun 2020
24.29M
Maximum
Jun 2023
17.00M
Average
16.47M
Median
Research and Development Expense (TTM) Benchmarks
| GT Biopharma Inc | 5.593M |
| Akoya Biosciences Inc | 21.67M |
| NovaBay Pharmaceuticals Inc | 0.061M |
| Palatin Technologies Inc | 25.13M |
| iBio Inc | 6.401M |